So-Young International (SY) Resumen de Acciones
So-Young International Inc. explota una plataforma en línea de servicios sanitarios de consumo en la República Popular China. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 3/6 |
| Crecimiento futuro | 5/6 |
| Rendimiento pasado | 0/6 |
| Salud financiera | 4/6 |
| Dividendos | 0/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en SY a partir de nuestros controles de riesgos.
SY Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de So-Young International Inc.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$2.67 |
| Máximo en las últimas 52 semanas | US$6.28 |
| Mínimo de 52 semanas | US$0.82 |
| Beta | 2.13 |
| Cambio en 1 mes | -4.64% |
| Variación en 3 meses | -14.97% |
| Cambio de 1 año | 211.19% |
| Variación en 3 años | 27.75% |
| Variación en 5 años | -73.08% |
| Variación desde la OPV | -85.33% |
Noticias y actualizaciones recientes
Actualización de narrativa • May 04
SY: Lower Impairments And Extended Buybacks Will Support Future Upside
Analysts have kept their $7.60 price target for So-Young International broadly unchanged, pointing to only minor tweaks in inputs such as discount rate, revenue growth, profit margin, and future P/E assumptions, rather than any major shift in their view on the stock. What's in the News For the fourth quarter ended December 31, 2025, So-Young International reported unaudited impairment of goodwill and long-lived assets of RMB 19,710,000 compared with RMB 540,009,000 a year earlier (company filing).Actualización de narrativa • Apr 19
SY: Lower Impairments And Extended Buybacks Will Support Future Upside
Analysts have trimmed their price target on So-Young International, reflecting updated assumptions that include a fair value estimate of $7.60, a revenue growth outlook of 29.36%, a profit margin of 1.65%, and a future P/E of 125.51, as they reassess the balance between growth expectations and profitability. What's in the News So-Young International reported unaudited consolidated impairment charges for the fourth quarter ended December 31, 2025, with impairment of goodwill and long-lived assets of RMB 19,710,000, compared with RMB 540,009,000 a year earlier (Key Developments).Recent updates
Actualización de narrativa • May 04
SY: Lower Impairments And Extended Buybacks Will Support Future Upside
Analysts have kept their $7.60 price target for So-Young International broadly unchanged, pointing to only minor tweaks in inputs such as discount rate, revenue growth, profit margin, and future P/E assumptions, rather than any major shift in their view on the stock. What's in the News For the fourth quarter ended December 31, 2025, So-Young International reported unaudited impairment of goodwill and long-lived assets of RMB 19,710,000 compared with RMB 540,009,000 a year earlier (company filing).Actualización de narrativa • Apr 19
SY: Lower Impairments And Extended Buybacks Will Support Future Upside
Analysts have trimmed their price target on So-Young International, reflecting updated assumptions that include a fair value estimate of $7.60, a revenue growth outlook of 29.36%, a profit margin of 1.65%, and a future P/E of 125.51, as they reassess the balance between growth expectations and profitability. What's in the News So-Young International reported unaudited consolidated impairment charges for the fourth quarter ended December 31, 2025, with impairment of goodwill and long-lived assets of RMB 19,710,000, compared with RMB 540,009,000 a year earlier (Key Developments).Actualización de narrativa • Feb 04
SY: Interim CFO Move And Steady Outlook Will Support Future Upside
Analysts have modestly adjusted their price target on So-Young International, reflecting small tweaks to inputs such as a slightly lower discount rate, steady fair value at about $7.74, and a marginally revised future P/E assumption based on their latest review of the company’s risk and growth profile. What's in the News Chief financial officer Hui Zhao has submitted his resignation from So-Young International, with his role ending on December 31, 2025, citing personal reasons (Key Developments).Actualización de narrativa • Jan 20
SY: Stable CFO Transition And Solid Guidance Will Support Future Earnings Multiple
Analysts have trimmed their price target on So-Young International slightly, citing small adjustments to the discount rate, profit margin outlook, and assumed future P/E multiple, while keeping fair value and revenue growth expectations broadly unchanged. What's in the News So-Young International received a resignation notice from chief financial officer Hui Zhao, who plans to step down effective December 31, 2025, citing personal reasons (company announcement).Actualización de narrativa • Jan 06
SY: Higher Profitability Assumptions Will Support Stronger Future Earnings Multiple
Analysts have lifted their price target on So-Young International by about 36%, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News So-Young International received a notice of resignation from chief financial officer Hui Zhao, who is set to leave the role effective December 31, 2025, citing personal reasons (Key Developments).Seeking Alpha • Aug 19
So-Young: Turning Positive On Sales Beat And Attractive Valuations (Rating Upgrade)
Summary I upgraded So-Young to "Buy" after its Q2 revenue beat expectations and the stock's post-earnings pullback created an attractive entry point. SY's successful pivot to branded aesthetic centers drove strong sequential sales growth, with this segment now accounting for 38% of total revenue. Despite ongoing losses and disappointing guidance, signs of operational improvement and profitability inflection are evident as clinic network expansion progresses. The stock's valuation is compelling at 1.0x forward EV/S, a discount to historical averages and peers. Read the full article on Seeking AlphaArtículo de análisis • Nov 13
Investors Give So-Young International Inc. (NASDAQ:SY) Shares A 34% Hiding
So-Young International Inc. ( NASDAQ:SY ) shareholders that were waiting for something to happen have been dealt a blow...Seeking Alpha • Oct 08
So-Young: Anticipating Both Top-Line Recovery And Margin Pressures
Summary So-Young International's revenue could recover and beat expectations going forward, if China is successful in stimulating the economy and boosting consumer confidence with new policies. SY's margins are expected to be negatively affected by the company's revenue mix shift toward lower-margin product sales and the growth in its clinic network. The mixed outlook warrants a Hold rating for So-Young International. Read the full article on Seeking AlphaArtículo de análisis • Sep 27
Potential Upside For So-Young International Inc. (NASDAQ:SY) Not Without Risk
It's not a stretch to say that So-Young International Inc.'s ( NASDAQ:SY ) price-to-earnings (or "P/E") ratio of 17.7x...Artículo de análisis • Aug 05
Is Now An Opportune Moment To Examine So-Young International Inc. (NASDAQ:SY)?
While So-Young International Inc. ( NASDAQ:SY ) might not have the largest market cap around , it saw significant share...Artículo de análisis • May 29
Many Still Looking Away From So-Young International Inc. (NASDAQ:SY)
With a price-to-sales (or "P/S") ratio of 0.5x So-Young International Inc. ( NASDAQ:SY ) may be sending bullish signals...Artículo de análisis • Apr 23
Is Now The Time To Look At Buying So-Young International Inc. (NASDAQ:SY)?
So-Young International Inc. ( NASDAQ:SY ), might not be a large cap stock, but it saw a significant share price rise of...Seeking Alpha • Mar 28
So-Young Dolls Up With Pivot To High-End Services
Summary So-Young reported an annual profit last year, reversing two years of losses, as its revenue rose 19%. The company’s new So-Young Prime service for high-end users helped to fuel a 22.2% revenue jump in its information services segment last year. The company’s evolution towards a more direct provider of cosmetic products and services is still a work in progress. Read the full article on Seeking AlphaArtículo de análisis • Feb 19
Market Cool On So-Young International Inc.'s (NASDAQ:SY) Revenues
You may think that with a price-to-sales (or "P/S") ratio of 0.6x So-Young International Inc. ( NASDAQ:SY ) is a stock...Artículo de análisis • Dec 07
What Is So-Young International Inc.'s (NASDAQ:SY) Share Price Doing?
While So-Young International Inc. ( NASDAQ:SY ) might not be the most widely known stock at the moment, it received a...Seeking Alpha • Sep 12
So-Young International: Tough Times
Summary So-Young International is facing tough times, due to weak economic conditions in China, the COVID-zero policy of the country, and regulatory headwinds for the Chinese medical aesthetics industry. SY saw its revenue decrease for the second straight quarter running in Q2 2022, and it turned from positive net income in Q2 2021 to losses in the recent quarter. On the flip side, So-Young International might deliver quarterly revenue beats in 2H 2022, assuming that the new product, So-Young Select, turns out to be more successful than expected. I have a Hold rating for SY; the new product So-Young Select could be a potential near-term catalyst, but the current operating environment for So-Young International is still too challenging to warrant a Buy rating for SY. Elevator Pitch My initial investment rating for So-Young International Inc.'s (NASDAQ:SY) shares is a Hold. It has been tough times for So-Young International in 2022 year-to-date, as seen with its topline decline for Q1 2022 and Q2 2022. There could be a short-term catalyst for SY in the form of better-than-expected results relating to its new product, So-Young Select. But the intermediate-term outlook for SY is still unfavorable, considering factors like China's macroeconomic environment, and new regulations which have a negative impact on the Chinese medical aesthetics market. Therefore, I think that a Hold (rather than Buy or Sell) rating is justified for So-Young International's stock. Challenging Operating Environment For The Chinese Medical Aesthetics Market So-Young International refers to itself as the operator of "the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry" in its media releases. SY generated 77% of its fiscal 2021 revenue from information services, or fees collected from service providers in exchange for sharing information about their medical aesthetics services in the community, according to its most recent 20-F filing. Reservations services (revenue relating to sales leads for service providers), and the sales of equipment & related maintenance services contributed the remaining 16% and 7% of its topline, respectively last year. Both So-Young International and the medical aesthetics industry in China have faced multiple headwinds in recent times. Firstly, China's economy is expected to slow in the foreseeable future, and this is evidenced by economists revising their 2022 and 2023 GDP growth estimates downwards as highlighted in a recent August 29, 2022 Bloomberg article. Given that medical aesthetics procedures are largely discretionary in nature, it is no surprise that short-term demand for medical aesthetics in China has weakened, and this also translates into lower revenue for So-Young International. Secondly, China appears to be persisting with the country's COVID-zero stance as it stands now. This implies that lockdowns and tighter pandemic restrictions will be seen in different parts of Mainland China from time to time when there is a spike in COVID-19 cases in specific areas. This is very disruptive for the Chinese medical aesthetics industry, where customers might be deterred or restricted from going outdoors to utilize related services. Similarly, users will be less keen to visit So-Young International's online platform and community to be updated on related developments in the medical aesthetics industry in China. Thirdly, the Mainland Chinese aesthetics market is facing significant regulatory pressures. A Reuters news article published a year ago on August 27, 2021 mentioned that "draft guidelines on regulation of the (Chinese) medical aesthetics sector's advertising" were issued with the aim to "crack down on ads that create anxiety over people's looks." Consulting firm Kline also noted in a May 27, 2022 write-up that Chinese regulatory authorities "issued four new regulations to rule out counterfeit products and unqualified institutions from the professional skin care market." While these new regulations were probably put in place with good intentions having the interests of Chinese consumers in mind, they will inevitably have a dampening effect on the growth of the medical aesthetics market in Mainland China. The tough operating conditions for So-Young International are reflected in the company's key recent financial and operating metrics as detailed in the subsequent section of the article. Key Financial And Operating Metrics For SY SY's revenue fell by -31.6% YoY from RMB452 million in the second quarter of 2021 to RMB309 million in the most recent quarter, as indicated in its Q2 2022 earnings press release. This marks the second consecutive quarter of topline contraction for So-Young International; SY's sales also declined by -16.5% YoY in the first quarter of this year. Prior to Q1 2022, So-Young International had delivered positive topline expansion in the seven quarters between Q2 2022 and Q4 2021. Notably, So-Young International's Q2 2022 revenue had benefited from the incremental sales of around RMB59 million contributed by its new sales of equipment & related maintenance services business segment, which was created with the acquisition of Wuhan Miracle Laser System in the prior year. Excluding the impact of the M&A transaction concluded in 2021, SY's adjusted organic revenue decline for the second quarter of the current year would have been even worse at -44.7% YoY (versus headline topline contraction of -31.6%). Also, SY reversed from positive non-GAAP adjusted earnings of +RMB73.7 million in Q2 2021 to record a non-GAAP adjusted net loss of -RMB22.7 million for Q2 2022. One key contributing factor is the negative effects of operating leverage, which resulted in a relatively larger drop in So-Young International's bottom line as compared to its topline contraction. Another key contributing factor is an unfavorable revenue mix, as SY's gross profit declined by -20.8 percentage points YoY to 66.2% in Q2 2022. The new sales of equipment & related maintenance services business segment or Wuhan Miracle Laser System boasted relatively inferior profitability as compared to the company's information services and reservation services business segments. The key operating metrics for So-Young International in the recent quarter were also disappointing. Monthly active users for SY decreased by-20.5% QoQ and -65.0% YoY to 3.5 million for Q2 2022. The total value of transactions executed in So-Young International's community and the number of paying users for SY shrunk by -35.8% YoY and -47.1% YoY to RMB353 million and 129,500, respectively in the recent quarter. Spotlight On So-Young's New Product Moving beyond the short-term headwinds for SY, the spotlight is on So-Young's new product launch.Seeking Alpha • Aug 16
So-Young International GAAP EPADS of -$0.06, revenue of $46.1M beats by $1.01M
So-Young International press release (NASDAQ:SY): Q2 GAAP EPADS of -$0.06. Revenue of $46.1M (-34.1% Y/Y) beats by $1.01M. For the third quarter of 2022, So-Young expects total revenues to be between RMB310 million (US$46.3 million) and RMB330 million (US$49.3 million), representing a 28.1% to 23.5% decrease from the same period in 2021. The above outlook is based on the current market conditions and reflects the Company’s preliminary estimates of market and operating conditions, as well as customer demand, which are all subjected to change, particularly in view of the potential impact of the COVID-19, the effects of which are difficult to analyze and predict.Seeking Alpha • Jul 18
So-Young receives minimum bid price notice from Nasdaq
So-Young International (NASDAQ:SY) has received a notification from Nasdaq indicating that for the last 30 consecutive business days, the closing bid price of the American depositary shares was below the minimum bid price of $1.00 per share. The company is granted a compliance period of 180 calendar days, or until January 11, 2023, to regain compliance under the Nasdaq Listing Rules. If the company does not regain compliance by January 11, 2023, it may be eligible for an additional 180-day compliance period. The Nasdaq notification letter does not affect the company’s business operations, and the company will take all reasonable measures to regain compliance within the prescribed grace period. Shares up 3% PM.Seeking Alpha • Jun 07
So-Young: Highly Attractive Risk-Reward Profile
So-Young is a small-cap internet company in China. The company operates the country’s leading online platform to connect buyers and sellers of medical aesthetic solutions. So-Young has 4.4 million monthly active users, which the company claims to be highly loyal and engaged. Speculators might find significant value based on three pillars: (1) the company can either find growth, (2) sustain/slightly increase profitability (3), or distribute net cash to shareholders. I calculate a fair base-case target price of $4.92/share and assign a Strong BUY recommendation on >400% upside potential. However, given the speculative nature of the trade, I also assign a High-Risk label.Artículo de análisis • Sep 15
So-Young International Inc.'s (NASDAQ:SY) 27% Cheaper Price Remains In Tune With Earnings
To the annoyance of some shareholders, So-Young International Inc. ( NASDAQ:SY ) shares are down a considerable 27% in...Seeking Alpha • Sep 13
Regulatory Wrinkles Spoil So-Young's Latest Results
So-Young International devotes much of its second-quarter results trying to ease investor concerns over a potential crackdown on China’s cosmetic surgery industry. Company’s revenue rises 37% and profit jumps sharply in latest quarter as business rebounds from year-ago pandemic-induced slowdown. It's quite possible So-Young could ultimately bounce back once the uncertainty lifts and it becomes clear the regulatory clampdown won't intensify.Seeking Alpha • Jul 01
Cosmetic Surgery Information Hub So-Young Dolls Up With Major Acquisition
Cosmetic surgery specialist So-Young International was probably hoping that news of the first major acquisition since its 2019 IPO would make it prettier to investors. So-Young announced its plan on Monday to purchase 85% of Wuhan Miracle Laser System, a laser medical equipment maker, for $122 million. So-Young's revenue reached 360 million yuan in the first three months of the year, roughly double the year-ago figure, which was hurt by the pandemic. The company just needs to find better ways to tell investors about its growth strategy, including the role for future major acquisitions like its new purchase of Wuhan Miracle Laser.Rentabilidad de los accionistas
| SY | US Interactive Media and Services | Mercado US | |
|---|---|---|---|
| 7D | -6.3% | -3.1% | -0.3% |
| 1Y | 211.2% | 68.4% | 26.7% |
Rentabilidad vs. Industria: SY superó a la industria US Interactive Media and Services, que obtuvo un rendimiento del 68.4% el año pasado.
Rentabilidad vs. Mercado: SY superó al mercado US, que obtuvo un rendimiento del 26.7% el año pasado.
Volatilidad de los precios
| SY volatility | |
|---|---|
| SY Average Weekly Movement | 9.1% |
| Interactive Media and Services Industry Average Movement | 8.7% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.2% |
Precio estable de las acciones: SY no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado US.
Volatilidad a lo largo del tiempo: La volatilidad semanal de SY ha disminuido de 15% a 9% en el último año.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2013 | 2,348 | Xing Jin | www.soyoung.com |
So-Young International Inc. gestiona una plataforma en línea de servicios sanitarios de consumo en la República Popular China. La empresa ofrece la aplicación móvil So-Young, que permite a los usuarios acceder a conocimientos de medicina estética, apoyo comunitario y opciones de reserva de tratamientos con profesionales médicos e instituciones de medicina estética; el miniprograma Weixin, que permite explorar opciones de tratamiento, consultar precios, concertar citas, participar en consultas en línea y realizar seguimientos; y contenido comunitario de medicina estética a través de su sitio web soyoung.com. Sus centros de estética ofrecen procedimientos de no invasivos a mínimamente invasivos, incluidas opciones basadas en dispositivos, como hilos tensores, luz pulsada intensa, estiramientos faciales por ultrasonidos, láseres de picosegundos y tratamientos de contorno corporal, así como tratamientos inyectables, incluidos potenciadores de la piel, productos basados en ácido hialurónico, botox y colágeno de tipo I y tipo III.
Resumen de fundamentos de So-Young International Inc.
| Estadísticas fundamentales de SY | |
|---|---|
| Capitalización bursátil | US$263.78m |
| Beneficios(TTM) | -US$35.62m |
| Ingresos (TTM) | US$223.94m |
1.2x
Ratio precio-ventas (PS)-7.5x
Ratio precio-beneficio (PE)¿Está SY sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de SY | |
|---|---|
| Ingresos | CN¥1.52b |
| Coste de los ingresos | CN¥795.72m |
| Beneficio bruto | CN¥727.69m |
| Otros gastos | CN¥969.99m |
| Beneficios | -CN¥242.30m |
Últimos beneficios comunicados
Dec 31, 2025
Próxima fecha de beneficios
May 22, 2026
| Beneficios por acción (BPA) | -2.42 |
| Margen bruto | 47.77% |
| Margen de beneficio neto | -15.91% |
| Ratio deuda/patrimonio | 2.4% |
¿Cómo se ha desempeñado SY a largo plazo?
Ver rendimiento histórico y comparativaDividendos
1.0%
Rentabilidad actual por dividendon/a
Ratio de pagosAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/21 23:05 |
| Precio de las acciones al final del día | 2026/05/21 00:00 |
| Beneficios | 2025/12/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
So-Young International Inc. está cubierta por 10 analistas. 2 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Austin Moldow | Canaccord Genuity |
| Guanran Wang | Citic Securities Co., Ltd. |
| null null | Citic Securities Co., Ltd. |